Tag: Sarepta Therapeutics

Sarepta Therapeutics shares continue to experience extreme volatility as promising clinical developments clash with significant safety concerns. The biotechnology firm ...

Sarepta Therapeutics witnessed a dramatic trading session as its stock price jumped more than 10%, closing at $21.32 before extending ...

Sarepta Therapeutics shares advanced 3.6% to $18.72 in the latest trading session, yet this modest gain conceals a deeply fractured ...

Sarepta Therapeutics shares closed Friday's trading session down 2.9 percent at $17.39, a decline that occurred despite a positive earnings ...

Sarepta Therapeutics finds itself at a pivotal crossroads as it transitions from the S&P MidCap 400 to the S&P SmallCap ...

Biotechnology firm Sarepta Therapeutics is confronting the most severe crisis in its corporate history. A combination of regulatory rejections for ...